Dr. Camillo Ricordi Delivers Inaugural Lecture Named in His Honor
One of the world’s leading diabetes researchers, Camillo Ricordi, M.D., Director of the University of Miami Miller School of Medicine’s Diabetes Research Institute (DRI), was chosen to deliver the keynote address at the Cell Transplant Society’s recent international congress in Melbourne, Australia. He delivered the inaugural Camillo Ricordi Lecture, named in his honor, on “Translational challenges and opportunities in cellular therapies and regenerative medicine.”
As a pioneer in developing islet cell transplantation techniques to restore insulin production, Ricordi was a natural choice for the prestigious lecture.
“The Cell Transplant Society would not exist without your vision and leadership,” said Maria Koulmanda, Ph.D., M.Sc., President of the worldwide organization. “The CTS Council felt it was only appropriate to celebrate your integral role in the creation of the society and your ongoing contributions to the field of cellular research by naming the first CTS lecture in your honor.”
“It was an honor to be asked to help inspire the current generation of researchers and surgeons in the development of new treatments and therapies utilizing cellular transplantation and regenerative medicine strategies,” said Ricordi, who is the Stacy Joy Goodman Professor of Surgery, Distinguished Professor of Medicine, Professor of Biomedical Engineering, Microbiology and Immunology, and Director of the DRI’s Cell Transplant Center.
Ricordi’s lecture was delivered on November 17 during the IPITA-IXA-CTS Joint Congress in Melbourne. He also spoke on several other topics, including, “Islet Isolation and Transplantation: Where Are We Now and Where Are We Going?”
Other contributions from the DRI included “nPOD and Beta Cell Autoimmunity,” presented by Alberto Pugliese, M.D., professor of medicine, and immunology and microbiology, and Head of the DRI Immunogenetics Program; “Islet Transplantation in the Immune Privileged Eye Anterior Chamber and Immune Tolerance Induction to Treat T1D,” presented by Midhat H. Abdulreda, Ph.D., assistant professor of surgery; “Engineering an Infectious Treg Biomimetic through Surface Bound TGF-β1 Polymers” and “Bioactive Covalent Layer-by-Layer Platforms for Cellular Encapsulation,” presented by Cherie Stabler, Ph.D. (University of Florida), and collaborators from the DRI; and “Microencapsulated Islet Survival, Function, and Host Responses” presented by Susan Safley, Ph.D. (Emory University), and collaborators from the DRI.
A former CTS president, Ricordi has received numerous honors and awards and was also knighted by the President of the Republic of Italy. He is currently serving on the editorial boards of CellR4 and Cell Transplantation. In 2013 he was appointed president of the Ri.MED Foundation by the Italian Prime Minister. He also serves as founding president of The Cure Alliance and chairman of the Diabetes Research Institute Federation. He has written more than 700 scientific publications and has been awarded 22 patents.